Copyright
©The Author(s) 2016.
World J Obstet Gynecol. Feb 10, 2016; 5(1): 97-101
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.97
Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.97
Table 1 Staging system for vulvar cancer of the international federation of gynaecology and obstetrics
| IA | Tumour confined to the vulva or perineum, ≤ 2 cm in size with stromal invasion ≤ 1 mm, negative nodes |
| IB | Tumour confined to the vulva or perineum, > 2 cm in size or with stromal invasion > 1 mm, negative nodes |
| II | Tumour of any size with adjacent spread (1/3 lower urethra, 1/3 lower vagina, anus), negative nodes |
| IIIA | Tumour of any size with positive inguino-femoral lymph nodes |
| (1) 1 lymph node metastasis greater than or equal to 5 mm | |
| (2) 1-2 lymph node metastasis(es) of less than 5 mm | |
| IIIB | (1) 2 or more lymph nodes metastases greater than or equal to 5 mm |
| (2) 3 or more lymph nodes metastases less than 5 mm | |
| IIIC | Positive node(s) with extracapsular spread |
| IVA | (1) Tumour invades other regional structures (2/3 upper urethra, 2/3 upper |
| vagina), bladder mucosa, rectal mucosa, or fixed to pelvic bone | |
| (2) Fixed or ulcerated inguino-femoral lymph nodes | |
| IVB | Any distant metastasis including pelvic lymph nodes |
Table 2 Correlation between depth of invasion and nodal metastasis in vulval SCC
| Depth of invasion | Percentage of positive nodes |
| < 1 mm | 0% |
| 1-2 mm | 7.6% |
| 2-3 mm | 8.4% |
| 3-5 mm | 26.7% |
| > 5 mm | 34.2% |
- Citation: Platt SL, Manley KM, Murdoch JB. Review of the current surgical management of vulval cancer. World J Obstet Gynecol 2016; 5(1): 97-101
- URL: https://www.wjgnet.com/2218-6220/full/v5/i1/97.htm
- DOI: https://dx.doi.org/10.5317/wjog.v5.i1.97
